Invasive aspergillosis (IA) is a serious hazard to haematological and critical care patients. Impactful risk factors for developing IA have been characterised; however, systematic analysis of baseline prognostic factors for treatment course of IA is missing. This paper provides a meta-analysis of all data from publications available from Pubmed from its inception to May 2018. It identifies predictors that may be used to identify patients at high risk for treatment failure.
This paper highlights the intrinsic resistance of strains from Aspergillus section Nigri to itraconazole and isavuconazole. Expression studies of cyp51A suggest that azole resistance in Aspergillus section Nigri is not clearly explained by Cyp51A protein alteration or by cyp51 gene upregulation, which indicates that other mechanisms might be involved.
Fungicides at environmentally relevant concentrations can promote the proliferation of toxic bloom-forming cyanobacteria by inhibiting natural fungal parasite epidemics. (Ortiz-Cañavate et al., 2019)
Cyanobacterial blooms raise serious public health concerns. This paper’s finding indicate that widely used agricultural fungicides, including itraconazole, might promote harmful algal blooms by inhibiting cyanobacterial natural antagonists such as chytrids, a group of primitive aquatic fungi.
Evaluation of Aspergillus IgG, IgM antibody for diagnosing in chronic pulmonary aspergillosis: A prospective study from a single center in China. (Guo et al., 2019)
This paper from China evaluates the effectiveness of Aspergillus IgG, IgM in diagnosing chronic pulmonary aspergillosis (CPA). The most common underlying disease in CPA patients was pulmonary tuberculosis and CPA patients were younger than those with other pulmonary disease. The most common clinical symptom was haemoptysis. The data presented indicates that Aspergillus-specific IgG, IgM could distinguish CPA from other pulmonary diseases effectively, and offers diagnostic value with regard to CPA.
Evaluation of a Novel Aspergillus Antigen Enzyme-Linked Immunosorbent Assay. (Dichtl et al., 2019)
This study compares the novel Aspergillus-specific galactomannoprotein (GP) enzyme-linked immunosorbent assay (ELISA) to the established Platelia Aspergillus galactomannan (GM) ELISA for the detection of invasive aspergillosis (IA). It finds that the sensitivity and specificity of the novel GP ELISA are similar to those of the Platelia GM ELISA. The authors note that the low sensitivities of both tests underline the need for serial testing in patients at risk for IA.